Sanofi US News

-- Focused effort to reach mothers, the family's "chief medical officer"

National AFib Education Campaign Launches to Help Improve the Care of People with This Serious and Increasingly Prevalent(1) Form of Irregular Heartbeat

- Weight gain was lowest in patients with baseline A1C below 8 percent and in patients 65 years and older -

- New phase III data from GetGoal-F1 study of once-daily lixisenatide support simplified treatment initiation -

Four local non-profits receive donations totaling more than $180,000

Positive impact from Genzyme on business EPS(1)

Greg Irace, Senior Vice President, Global Services

Early shipments of Fluzone and Fluzone High-Dose vaccines support health-care providers in immunization planning and provide additional opportunities to increase immunization rates

- Strategic Divestiture to focus on Growth Platforms in the United States and Canada -

Company has sponsored high school biotechnology competition for almost 20 years

- Data Presented at American Diabetes Association's 71st Annual Scientific Sessions -

- Once-Daily Lyxumia® Demonstrates Non-Inferior Reduction of Blood Glucose and Less Hypoglycemia versus Exenatide Twice Daily in Type 2 Diabetes Patients -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

- Over 500 Million Patients Suffer from Hearing Loss Worldwide with No Currently Available Disease-Modifying Treatments -

Diabetes Co-Stars: Cook-Off Invites People to Share Diabetes-Friendly Recipes

Donation Helps Four-time NASCAR Cup Series Champion Jeff Gordon Shift Relief Efforts into High Gear

- Results of Phase III SAVE-ONCO study selected for "Best of ASCO 2011" -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle

- Indication Provides New Option to Help Protect Earlier Against Meningococcal Disease -

"AFib in America: State Impact Reports" Illustrate the Disconnect Between AFib's Impact and the Public Health Resources Available

The Coalition to Prevent DVT Promotes Education to Fill the Gap between DVT Risk and Co-Morbid Patients

Sanofi Pasteur stands shoulder to shoulder with Rotary International during NYSE and EURONEXT bell-ringing ceremonies

- WNBA, NBA Development League and NBA All-Star Dwight Howard, WNBA All-Star Alana Beard and NBA Legends Walt Frazier and Chris Dudley will also Raise Awareness about Diabetes -

Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its footprint in biotechnology

- First industry partner for UCSF's Program for Breakthrough Biomedical Research (PBBR) -

- Collaboration promotes clinical and translational research to address unmet needs of cancer patients in India -

Final 10-year combination chemotherapy adjuvant survival data, studies of investigational agent iniparib to be featured at breast cancer symposium

Vaccine against one of the most common causes of hospital-acquired infection in North America & Europe tested in the U.S.

Investigational Intradermal Influenza Vaccine Induced Comparable Immune Responses to Licensed Fluzone Vaccine with Less Antigen, Smaller Injection Volume

- Focused on translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation -

World’s Largest Influenza Vaccine Producer Awarded $57 Million To Maintain Year-Round Egg Supply for Influenza Pandemic Planning

- Results of the Phase III TROPIC global study published -

Technology of in-vitro Models of the Human Immune System to Provide Competitive Advantage in Vaccine Development